MD and CEO Pankaj Jashwant Shah resigns effective August 3, 2026

CEO resignedKey managerial personnel resignedManagement Changes View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.0%Reaction day

₹115.80

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.4%-2.4% vs market

Healthcare Service Provider peers, median of 27sector+1.1%-3.1% vs sector

On the reaction day the stock moved 2.4 pts less than Nifty Microcap 250 and 3.1 pts less than its Healthcare Service Provider peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.0+0.4-2.4+1.1-3.1

Next day

-3.9+1.7-5.7+1.3-5.2

-5.8+2.1-7.9-0.2-5.6

-7.7+2.1-9.8-0.2-7.5

-9.5+2.1-11.6+0.8-10.3

-11.3+1.9-13.2+0.6-11.9

-12.3+2.4-14.8+1.4-13.8

15d

-25.3+3.0-28.3+0.6-25.9

-16.2+3.7-20.0-0.1-16.2

+8.0+1.6+6.5-4.3+12.4

+21.5-2.7+24.2-7.6+29.1

UpDownMarket · Nifty Microcap 250Sector · Healthcare Service Provider peers, median of 27Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Mr. Pankaj Jashwant Shah (DIN 02836324) has resigned as Managing Director and Chief Executive Director of Aspira Pathlab and Diagnostics with immediate effect from August 3, 2026, citing personal reasons. No replacement or interim arrangement has been announced in this filing. The communication was signed by Executive Director Nikunj Mange on behalf of the company. The exit leaves the top leadership post vacant pending a successor decision by the Board.

Likely market impact

Sudden exit of the top executive with no named successor may create short-term leadership uncertainty and could weigh on sentiment until a replacement is announced.